cholecalciferol and Colorectal-Neoplasms--Hereditary-Nonpolyposis

Colorectal cancer (CRC) is the second most common malignancy in the world and a leading cause of cancer death. Prevention can lead to decreased incidence of this neoplasm. Chemoprevention may be one option. The article presents a summary of the main information on CRC chemoprevention based on internet database MEDLINE.

Topics: Adenomatous Polyposis Coli; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Calcium; Chemoprevention; Cholecalciferol; Colonoscopy; Colorectal Neoplasms; Colorectal Neoplasms, Hereditary Nonpolyposis; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Early Diagnosis; Folic Acid; Humans; Mass Screening; Randomized Controlled Trials as Topic; Rectal Neoplasms; SEER Program